MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01312nam a2200313 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
vtls000068300 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KUKTEM |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251125093905.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
130129t2010 enka f 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781849730457 (set) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781849730631 (v. 1) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781849730648 (v. 2) |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
|---|
| Level of rules in bibliographic description |
201311130944 |
| Level of effort used to assign nonsubject heading access points |
saini |
| Level of effort used to assign subject headings |
201301290917 |
| Level of effort used to assign classification |
asmadi |
| -- |
201301290913 |
| -- |
asmadi |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UMP |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
RC523 .E44 2010 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Emerging drugs and targets for Alzheimer’s disease / |
| Statement of responsibility, etc. |
edited by Ana Martinez |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Cambridge : |
| Name of publisher, distributor, etc. |
Royal Society of Chemistry, |
| Date of publication, distribution, etc. |
c2010 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
2 v. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
RSC drug discovery series, |
| International Standard Serial Number |
2041-3203 ; |
| Volume/sequential designation |
no. 2-3 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
v. 1. Beta-amyloid, tau protein and glucose metabolism -- v. 2. Neuronal plasticity, neuronal protection and other miscellaneous strategies |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Alzheimer’s disease |
| General subdivision |
Chemotherapy |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug targeting |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
MartiÌnez, Ana, |
| Dates associated with a name |
1961- |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Royal Society of Chemistry (Great Britain) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
RSC drug discovery series ; |
| Volume/sequential designation |
2 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
RSC drug discovery series ; |
| Volume/sequential designation |
3 |